Featured Publications
Mouse Models to Study Natural Killer Cell-Mediated Immunosurveillance and Metastatic Latency.
Nair VR, Malladi S Methods Mol. Biol. 2019 1884 141-150
Metastatic Latency, a Veiled Threat.
Kim K, Marquez-Palencia M, Malladi S, Front Immunol 2019 10 1836
Er EE, Valiente M, Ganesh K, Zou Y, Agrawal S, Hu J, Griscom B, Rosenblum M, Boire A, Brogi E, Giancotti FG, Schachner M, Malladi S, Massagué J Nat. Cell Biol. 2018 Aug 20 8 966-978
Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT.
Malladi S, Macalinao DG, Jin X, He L, Basnet H, Zou Y, de Stanchina E, Massagué J Cell 2016 Mar 165 1 45-60
Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma.
Zhang XH, Jin X, Malladi S, Zou Y, Wen YH, Brogi E, Smid M, Foekens JA, Massagué J Cell 2013 Aug 154 5 1060-73
A CXCL1 paracrine network links cancer chemoresistance and metastasis.
Acharyya S, Oskarsson T, Vanharanta S, Malladi S, Kim J, Morris PG, Manova-Todorova K, Leversha M, Hogg N, Seshan VE, Norton L, Brogi E, Massagué J Cell 2012 Jul 150 1 165-78
The Apaf-1*procaspase-9 apoptosome complex functions as a proteolytic-based molecular timer.
Malladi S, Challa-Malladi M, Fearnhead HO, Bratton SB EMBO J. 2009 Jul 28 13 1916-25
Wu CC, Lee S, Malladi S, Chen MD, Mastrandrea NJ, Zhang Z, Bratton SB Nat Commun 2016 Nov 7 13565
Fisher AA, Labenski MT, Malladi S, Chapman JD, Bratton SB, Monks TJ, Lau SS Toxicol. Sci. 2011 Jul 122 1 64-72
Deletion mutational analysis of BMRP, a pro-apoptotic protein that binds to Bcl-2.
Malladi S, Parsa KV, Bhupathi D, Rodríguez-González MA, Conde JA, Anumula P, Romo HE, Claunch CJ, Ballestero RP, González-García M Mol. Cell. Biochem. 2011 May 351 1-2 217-32